BioSpace News Archive

The intention is to focus its research efforts on cancer, immunology, rare diseases and vaccines. The changes will result in the loss of 466 jobs in the two countries.

Chief Operating Officer Dan Paterson has been appointed to the role of president and will lead the company while the board of directors conducts a search for a new CEO.

The public’s perception of the drug industry can be confusing. Recent studies take a hard look at the industry from different perspectives.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Merck anticipates Keytruda’s approved indications to more than double over the next five years and anticipates its oncology pipeline winning more than 50 approvals over the same time period.

Biotech and pharma companies strengthen their leadership teams and committees with new appointments.

Polyphor AG announced that it will provide an overview on its Outer Membrane Protein Targeting Antibiotics programs at the American Society of Microbiology Microbe 2019 Conference taking place in San Francisco, California, from June 20 to 24, 2019.

Partnership secures access to reserved cGMP capacity and resources at Yposkesi for manufacturing to support the global development and commercialization of Axovant’s gene therapy programs

Spero Therapeutics, Inc. announced that it entered into a collaboration with the Bill & Melinda Gates Medical Research Institute to develop SPR720 for the treatment of lung infections caused by Mycobacterium tuberculosis, an indication that is designated as a critical concern by the World Health Organization.

Clinical stage cannabinoid company Botanix Pharmaceuticals Limited is pleased to announce new data from studies recently conducted with its antimicrobial product BTX 1801.